InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,307.01
(
-0.27%
)
US TECH 100
18,386.80
(
0.87%
)
Dow Jones
39,671.04
(
-0.51%
)
Brent Oil
81.83
(
0.36%
)
Bitcoin
69,567.82
(
0.67%
)
Post# of 251903
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: tony111 post# 87461

Monday, 12/14/2009 5:17:59 PM

Monday, December 14, 2009 5:17:59 PM

Post# of 251903
The stock price is being held back by the company's balance sheet along with 1) uncertainty around the MRK relationship and 2) uncertainty around the timing of a AP534 partnership. My guess is MRK is playing hardball in order to also partner 534. Novartis has gleevec and tasigna while BMS has sprycel so it seems like it would be a good fit for MRK. btw, I agree that Berger leaves a lot to be desired...last December was just a train wreck.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up